Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The biological pathways of Alzheimer disease: a review
Marco Calabrò, Carmela Rinaldi, Giuseppe Santoro, et al.
AIMS neuroscience (2020) Vol. 8, Iss. 1, pp. 86-132
Open Access | Times Cited: 183

Showing 1-25 of 183 citing articles:

Neuroprotective Herbs for the Management of Alzheimer’s Disease
Julie Gregory, Yasaswi Vengalasetti, Dale E. Bredesen, et al.
Biomolecules (2021) Vol. 11, Iss. 4, pp. 543-543
Open Access | Times Cited: 162
Natural acetylcholinesterase inhibitors: A multi-targeted therapeutic potential in Alzheimer's disease
Gajendra Kumar, G. Pratap, D Poornima, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 11, pp. 100154-100154
Open Access | Times Cited: 22
Drug delivery strategies with lipid-based nanoparticles for Alzheimer’s disease treatment
Young‐Ju Jang, Seong-Jun Kang, Hyun Su Park, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 4
In silico insights into the structural and electronic properties of cobalt coordination compounds obtained from Schiff bases with bulky fragments
Elizaveta V. Panova, Damir A. Safin
Computational and Theoretical Chemistry (2025), pp. 115082-115082
Closed Access | Times Cited: 2
Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan
Shikha Snigdha, Kevin Ha, Paul Tsai, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107978-107978
Closed Access | Times Cited: 96
New Promising Therapeutic Avenues of Curcumin in Brain Diseases
Tarek Benameur, Giulia Giacomucci, Maria Antonietta Panaro, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 236-236
Open Access | Times Cited: 74
Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted Delivery
Duygu Ege
Materials (2021) Vol. 14, Iss. 12, pp. 3332-3332
Open Access | Times Cited: 60
MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases
T. P. Nhung Nguyen, Mandeep Kumar, Ernesto Fedele, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4718-4718
Open Access | Times Cited: 52
Bioactive Compounds of the Mediterranean Diet as Nutritional Support to Fight Neurodegenerative Disease
Gianluca Antonio Franco, Livia Interdonato, Marika Cordaro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7318-7318
Open Access | Times Cited: 36
Unveiling the potential of molecular imprinting polymer-based composites in the discovery of advanced drug delivery carriers
Amit Kumar, Satadru Kashyap, Farhan Mazahir, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 11, pp. 104164-104164
Closed Access | Times Cited: 14
A multidimensional study for design functional foods: Chemical profiling, antioxidant potential, enzyme inhibition, and cytotoxic effects of Alkanna tubulosa extracts
Gökhan Zengin, Milena Terzić, Nurgül Abul, et al.
Food Bioscience (2024) Vol. 60, pp. 104280-104280
Closed Access | Times Cited: 11
Cellular junction dynamics and Alzheimer’s disease: a comprehensive review
Keyvan Asghari, Zahra Niknam, Shadi Mohammadpour-Asl, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 10
Gold Nanoparticle-Decorated Catalytic Micromotor-Based Aptassay for Rapid Electrochemical Label-Free Amyloid-β42 Oligomer Determination in Clinical Samples from Alzheimer’s Patients
Álvaro Gallo-Orive, María Moreno‐Guzmán, Marta Sánchez-Paniagua, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 14, pp. 5509-5518
Open Access | Times Cited: 9
Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer's disease: Where are our knowledge
Shahram Darabi, Enam Alhagh Charkhat Gorgich, Fatemeh Moradi, et al.
IBRO Neuroscience Reports (2025) Vol. 18, pp. 191-199
Closed Access | Times Cited: 1
The roles of intrinsically disordered proteins in neurodegeneration
Kagistia Hana Utami, Satoru Morimoto, Yasue Mitsukura, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2025), pp. 130772-130772
Open Access | Times Cited: 1
A review on omics-based biomarkers discovery for Alzheimer's disease from the bioinformatics perspectives: Statistical approach vs machine learning approach
Mei Sze Tan, Phaik‐Leng Cheah, Ai‐Vyrn Chin, et al.
Computers in Biology and Medicine (2021) Vol. 139, pp. 104947-104947
Closed Access | Times Cited: 49
Investigation of the peripheral inflammation (neutrophil–lymphocyte ratio) in two neurodegenerative diseases of the central nervous system
Sonat Pınar Kara, Bengü Altunan, Aysun Ünal
Neurological Sciences (2021) Vol. 43, Iss. 3, pp. 1799-1807
Open Access | Times Cited: 47
High-Throughput Screening and Molecular Dynamics Simulation of Natural Product-like Compounds against Alzheimer’s Disease through Multitarget Approach
Danish Iqbal, Md Tabish Rehman, Abdulaziz Bin Dukhyil, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 937-937
Open Access | Times Cited: 45
Alzheimer’s disease large-scale gene expression portrait identifies exercise as the top theoretical treatment
Mason A. Hill, Stephen C. Gammie
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Neuroinflammation as a mechanism linking hypertension with the increased risk of Alzheimer’s disease
Andis Klegeris, Ekta Bajwa
Neural Regeneration Research (2022) Vol. 17, Iss. 11, pp. 2342-2342
Open Access | Times Cited: 31
Most Pathways Can Be Related to the Pathogenesis of Alzheimer’s Disease
Sarah Morgan, Pourya Naderi Yeganeh, Katjuša Koler, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 30
Cerebrospinal fluid: A specific biofluid for the biosensing of Alzheimer's diseases biomarkers
Arezoo Mirzaie, Hassan Nasrollahpour, Balal Khalilzadeh, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 166, pp. 117174-117174
Closed Access | Times Cited: 17
Sildenafil as a Candidate Drug for Alzheimer’s Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons
Dhruv Gohel, Pengyue Zhang, Amit Gupta, et al.
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 2, pp. 643-657
Open Access | Times Cited: 7
Selenium-containing compounds: a new hope for innovative treatments in Alzheimer’s disease and Parkinson’s disease
Patryk Pyka, Sabrina Garbo, Rossella Fioravanti, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104062-104062
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top